Yucong Xue

774 citations
29 papers · 609 indexed · h-index 15
Topics
Ginger and Zingiberaceae research (6 papers)Ion channel regulation and function (5 papers)Retinoids in leukemia and cellular processes (5 papers)

In The Last Decade

Yucong Xue

27 papers receiving 600 citations

Peers

Yucong Xue
Comparison fields: 5 of 85
  • Molecular Biology 299
  • Pharmacology 126
  • Complementary and alternative medicine 77
  • Cardiology and Cardiovascular Medicine 76
  • Oncology 62
Replace Asjad Visnagri with:
Asjad Visnagri United Kingdom
Ebtehal El‐Demerdash Egypt
Shengjiang Guan China
Fatemeh Yarmohammadi Iran
Huiqin Xu China
Vinay Kondeti United States
Xueyan Zhou China
Kahkashan Rashid India
Müslüm Kuzu Türkiye
Zeng-Chun Ma China
Yucong Xue relative to Asjad Visnagri United Kingdom Asjad Visnagri's profile →
Citations per field
00.5×1.5×1.8×
Asjad Visnagri · 1×
Citations per year

Countries citing papers authored by Yucong Xue

Since Specialization
Citations

This map shows the geographic impact of Yucong Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yucong Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yucong Xue more than expected).

Fields of papers citing papers by Yucong Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yucong Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yucong Xue. The network helps show where Yucong Xue may publish in the future.

Co-authorship network of co-authors of Yucong Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Yucong Xue. A scholar is included among the top collaborators of Yucong Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yucong Xue. Yucong Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 9
4 14
5 11
6 3
7 21
8 31
9 83
10 55
11 28
12 7
13 32
14 63
15 16
16 26
17 26
18 31
19 15
20 53

About Yucong Xue

Yucong Xue is a scholar working on Pharmacology, Complementary and alternative medicine and Neurology, having authored 29 papers that have together received 609 indexed citations. Recurring topics across this work include Ginger and Zingiberaceae research (6 papers), Ion channel regulation and function (5 papers) and Retinoids in leukemia and cellular processes (5 papers). The work is most often cited by research in Pharmacology (126 citations), Complementary and alternative medicine (77 citations) and Biochemistry (40 citations). Yucong Xue has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Li Chu, Jianping Zhang, Xi Chu, Xue Han, Muqing Zhang, Xue Han, Shengjiang Guan, Miaomiao Liu, Panpan Liu and Xuan Zhang. Their work appears in journals such as British Journal of Pharmacology, Journal of Ethnopharmacology and Journal of Cellular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026